Evidence-Based Medicine Guidelines
Factor Xa inhibitors versus vitamin K antagonists for preventing embolism in patients with atrial fibrillation
Factor Xa inhibitors versus vitamin K antagonists for preventing embolism in patients with atrial fibrillation is a topic covered in the Evidence-Based Medicine Guidelines.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Factor Xa Inhibitors Versus Vitamin K Antagonists for Preventing Embolism in Patients With Atrial Fibrillation." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/458170/all/Factor_Xa_inhibitors_versus_vitamin_K_antagonists_for_preventing_embolism_in_patients_with_atrial_fibrillation.
Factor Xa inhibitors versus vitamin K antagonists for preventing embolism in patients with atrial fibrillation. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/458170/all/Factor_Xa_inhibitors_versus_vitamin_K_antagonists_for_preventing_embolism_in_patients_with_atrial_fibrillation. Accessed March 29, 2023.
Factor Xa inhibitors versus vitamin K antagonists for preventing embolism in patients with atrial fibrillation. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/458170/all/Factor_Xa_inhibitors_versus_vitamin_K_antagonists_for_preventing_embolism_in_patients_with_atrial_fibrillation
Factor Xa Inhibitors Versus Vitamin K Antagonists for Preventing Embolism in Patients With Atrial Fibrillation [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 March 29]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/458170/all/Factor_Xa_inhibitors_versus_vitamin_K_antagonists_for_preventing_embolism_in_patients_with_atrial_fibrillation.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Factor Xa inhibitors versus vitamin K antagonists for preventing embolism in patients with atrial fibrillation
ID - 458170
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/458170/all/Factor_Xa_inhibitors_versus_vitamin_K_antagonists_for_preventing_embolism_in_patients_with_atrial_fibrillation
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
